Growth hormone exerts direct and indirect effects ... further studies are needed to assess the potential role of this adjuvant therapy in heart failure patients.

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and ...

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal ...

Declining testosterone levels can impact bone density, red blood cell production, mood, sleep, and more. So, should you ...

Early menopausal hormone therapy neither benefits nor harms long-term cognition, offering reassurance but no protection ...

A study highlights significant body composition changes and increased cardiovascular risks in transgender men on testosterone ...

Research from Karolinska Institutet shows that long-term sex hormone treatment in transgender individuals can lead to ...

In patients with hormone-sensitive breast cancer tumor growth is mainly driven by estrogen and patients are therefore treated with estrogen-suppressing drugs, often tamoxifen. However, anti-hormonal ...

New research shows that long-term sex hormone treatment in transgender individuals can lead to significant changes in body composition and risk factors for cardiovascular disease, particularly in ...

In 1985, recombinant human growth hormone was approved for the treatment of children with growth hormone deficiency. This therapeutic agent was among the first drugs to be produced by recombinant ...

Today, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal ...

In January 2024, researchers in the U.K. published a study in the journal Nature Medicine proposing that several people who received cadaveric growth hormone between 1959 and 1989 as a treatment ...